Share Name Share Symbol Market Type Share ISIN Share Description
Skinbiotherap. LSE:SBTX London Ordinary Share GB00BF33H870 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 8.875p 8.75p 9.00p 8.875p 8.875p 8.875p 11,112 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology - - - - 10.54

Skinbiotherap. Share Discussion Threads

Showing 526 to 548 of 550 messages
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
DateSubjectAuthorDiscuss
14/8/2017
12:28
THAT HEALTH AND SAFTEY APPLICATION for their first product line will be granted very soon imo....then the price action will start.
ibug
14/8/2017
08:20
Some decent size buys have been popping up recently, feels like we're close to news?
trotterstrading
10/8/2017
14:44
TROTTER YOU ARE SPOT ON RIGHT ABOUT THAT according to the FT free float = Free float 23.11m shares htTps://markets.ft.com/data/equities/tearsheet/summary?s=SBTX:LSE
ibug
10/8/2017
12:09
Just needs an update and she will take off. Very little free float
trotterstrading
08/8/2017
16:30
THE COMPANY ARE WAITING FOR HEALTH AND SAFTEY APPROVAL...once granted then clinical trials can start and then the share price will light up imo.
ibug
08/8/2017
16:26
promising background information notwithstanding, seems to me I'm the only (very) modest buyer here to-day; something similar to a few days ago. Does market know something I don't. If only if were the other way round. Access at ipo isn't registering any takers; what can the matter be?
owenmo
07/8/2017
14:57
That article shows that the SBTX research has advanced and is on the cusp of having a working clinical cream that can help to heal wounds to the skin. That market is massive. In a recent study published in the journal Scientific Reports, Dr. O'Neill further showed that the two lactobacilli had different effects on skin cells in a wound healing model. L. rhamnosus GG mostly promoted cell migration, allowing the cells to close the artificial wound rapidly, while L. reuteri increased rates of cell division, helping to replenish the pool of cells destroyed by the creation of the wound. This study used bacterial extracts rather than living cells.
ibug
06/8/2017
16:17
THANKS PAROB--- we have ground breaking knowledge being developed by a world renown expert: Probiotic bacteria show promising potential Do bacteria have antibacterial properties? Yes, they do; they naturally compete with each other for living space and food. To achieve this, bacteria produce antimicrobial molecules that specifically prevent the growth of other bacteria by altering the growth environment in their favor and by disrupting communication between other bacterial cells. Catherine O'Neill, Ph.D. - senior lecturer in the Division of Musculoskeletal and Dermatological Science at the University of Manchester in the United Kingdom - and her team have tried to harness these properties by using bacteria to prevent pathogen infections. But does skin harbor suitable bacteria? In response to that question, Dr. O'Neill told Medical News Today, "We really don't have any idea of skin probiotics. We don't know enough about the skin's microbiome and how it interacts with the wound." Instead, she uses lactobacillus bacteria, which are a group of so-called friendly bacteria, in her research. Lactobacilli are mostly harmless and some strains are a crucial component of our daily lives in that they facilitate the fermentation of products such as yogurt, beer, and wine. Dr. O'Neill's team showed that both L. rhamnosus GG and L. reuteri could protect skin cells in the laboratory from infection by S. aureus. This was true when live bacteria were added to the skin cells and when the bacteria were killed and their extracts added instead. In a recent study published in the journal Scientific Reports, Dr. O'Neill further showed that the two lactobacilli had different effects on skin cells in a wound healing model. L. rhamnosus GG mostly promoted cell migration, allowing the cells to close the artificial wound rapidly, while L. reuteri increased rates of cell division, helping to replenish the pool of cells destroyed by the creation of the wound. This study used bacterial extracts rather than living cells. Dr. O'Neill told MNT that she sees bacterial extracts as a safer way to treat patients because there are incidences when lactobacillus bacteria have entered into the bloodstream of immunocompromised patients and caused harm. "I doubt you'd get any clinician to put live bacteria onto a wound [in the U.K.]," she explained. "We'd have a lot more success getting a dead organism through ethics committees."
ibug
05/8/2017
13:17
Dr Catherine O'Neill and her work mentioned in this article published on Thursday: Could probiotics replace antibiotics in wound healing? hTTp://www.medicalnewstoday.com/articles/318765.php Probiotic bacteria show promising potential
parob
02/8/2017
10:37
The sbtx share price should get some sparkle soon imo.
ibug
02/8/2017
10:35
Its all about the definition change about hygiene it is being redefined to include microorganisms and that will create a huge market for SBTX.
ibug
02/8/2017
10:35
As hygiene is being redefined to include microorganisms it appears the SBTX clinical cream could become widely used by medical professionals as a barrier cream against pathogenic microorganisms...WHICH IS A HUGE MARKET imo. Cleanliness in context: reconciling hygiene with a modern microbial perspective This review focuses on the concept of hygiene as it relates to the human-associated microbiota, with the aim of coming to a clear, workable definition of hygiene that is congruent with our emerging understanding of the intimate, multifaceted, and symbiotic relationships that humans have with microorganisms. After conducting a thorough review of peer-reviewed literature on hand hygiene, the skin microbiota, hand washing, and hand drying (compiling over 200 papers), we systematically examined both clinical and commonplace definitions of hygiene and re-evaluated the concept in the context of a modern understanding of human-associated microbial ecology. By doing this, we bridged a gap between the clinical skin microbiology literature and the emerging human-associated microbial ecology literature. Given the intimate interactions between humans and our microbiota, it is becoming apparent that maintenance and promotion of healthy human-associated microbial communities is necessary for good health. As such, we argue that the concept of hygiene as akin to sterilization no longer serves a useful role in scientific or medical discourse. It is more useful to explicitly define hygiene in terms of health outcomes and focus on the use of quantitative, modern molecular biology tools to elucidate the complex ecological interactions that relate hygienic practice to the spread of disease. Pursuant to that goal, we have explicitly defined hygiene as “those actions and practices that reduce the spread or transmission of pathogenic microorganisms, and thus reduce the incidence of disease.” htTps://microbiomejournal.biomedcentral.com/articles/10.1186/s40168-017-0294-2
ibug
02/8/2017
10:34
OPTI interviewed by TW and SBTX got mentioned....sounded very positive, news coming soon. htTp://issuu.com/ukinvestormagazine/docs/july_2017_uk_investor_magazine/2?ff=true&e=17910782/51085584
ibug
02/8/2017
10:34
The Human Microbiome -The human body has around 10X more bacteria within it, and on it than human cells -The collective name for all the genes in all the bacteria is 'the microbiome' -The microbiome consists of around 1000,000 genes – humans have around 23,000 -The microbiome has huge potential to change how the body functions Skinbiotix SkinBioTherapeutics uses lysates (extracts) of probiotic bacteria that have been shown to: -Increase the skins barrier integrity by enhancing the formation of multi-protein complexes called ‘tight junctions’. Tight junctions seal the space between adjacent gut cells to prevent the passage of toxins, molecules and ions through these spaces -Protect the Skin from infection by outcompeting harmful pathogens -Increase the rate of Skin healing in response to injury hTtp://www.skinbiotherapeutics.com/technology.php
ibug
02/8/2017
10:26
Yes Raf, it is a bit quiet...
semper vigilans
02/8/2017
10:25
Could do with something to give the share price a lift here.
rafboy
28/7/2017
23:00
Ill performing pile of shyte But Our time will come :)
judijudi
27/7/2017
19:43
BB's bang on the money!! :)
judijudi
24/7/2017
20:00
https://www.britishbulls.com/SignalPage.aspx?lang=en&Ticker=SBTX.L
parob
24/7/2017
15:33
blimey ... lucky call by me ;o)
onedayrodders
24/7/2017
10:40
Trading looking brisk this morning ahead of much anticipated news flow. Here are some of the top trades: 10:06 - 24/07 Buy 70734 9.48p £6,702.05 08:01 - 24/07 Buy 50000 8.94p £4,470.00 10:01 - 24/07 Buy 32335 9.25p £2,990.99 10:03 - 24/07 Buy 30000 9.25p £2,775.00 09:09 - 24/07 Buy 30000 9.20p £2,760.00
ibug
24/7/2017
09:22
Only 10k for me this morning but every little helps!
rafboy
24/7/2017
08:04
SOH backed UOM's technology after weighing up various options for investment, and I'm backing him. Look what happened to OPTI! Another 50K for me, rude not to at the IPO price given SOH's family participated in the IPO. John, Thomas and Kate O'Hara bought over 1.25M shares in total. Page 64 of the admission doc: hTTp://www.skinbiotherapeutics.com/downloads/admission-document.pdf Would be very surprised if this dropped any lower. We are at, or very close to the bottom IMO.
parob
Chat Pages: 22  21  20  19  18  17  16  15  14  13  12  11  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:33 V: D:20170817 13:55:47